Institute Director at Georgia Tech Named Chairperson of NIH Study Section

Primary tabs

Robert E. Guldberg, director of Georgia Tech’s Parker H. Petit Institute for Bioengineering and Bioscience (IBB), has been appointed chairperson of the Musculoskeletal Tissue Engineering Study Section in the Center for Scientific Review – part of the National Institutes of Health.

Guldberg will serve as chairperson of the study section from July 1, 2011, to June 30, 2013. The study section will contribute to the national biomedical research effort and assure the quality of the NIH peer review process.

Guldberg's research interests focus on musculoskeletal growth and development, functional regeneration following traumatic injury and degenerative diseases, including skeletal fragility and arthritis

According to Dr. Toni Scarpa, director of the Center for Scientific Review in NIH’s Department of Health and Human Services, Guldberg was selected for the chair position because of his demonstrated achievement in his scientific discipline, quality of research accomplishments, publications in scientific journals and overall judgment and objectivity.

At Georgia Tech, Guldberg studies cell-based therapies, bone biomechanics, musculoskeletal injury, joint degeneration, biomaterials and delivery, and micro-CT imaging. His laboratory creates strategies and enables technologies for the functional restoration of damaged or degenerated musculoskeletal tissues, with a focus on bone and cartilage.

In 1996, Guldberg joined Georgia Tech, serving both in IBB and the George W. Woodruff School of Mechanical Engineering. He was appointed director of IBB in November 2009.

Guldberg holds an undergraduate degree in mechanical engineering, a master’s degree in bioengineering and mechanical engineering, and a Ph.D. in mechanical engineering from the University of Michigan.




  • Workflow Status:
  • Created By:
    Liz Klipp
  • Created:
  • Modified By:
    Fletcher Moore
  • Modified:


    No categories were selected.

Target Audience

    No target audience selected.